iPS Cell Differentiation
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
Stem Cell Therapy for Tissue Regeneration
Stem Cell Culture
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Mar 8, 2026

Author Spotlight: Advancing Vision Restoration - Stem Cell-Based Therapy for Retinal Diseases
Published on: October 6, 2023
Aakriti Garg1, Jin Yang2,3, Winston Lee4,5
1Jonas Children's Vision Care, and Bernard & Shirlee Brown Glaucoma Laboratory, Department of Ophthalmology, Columbia University Medical Center, Edward S. Harkness Eye Institute, 635 West 165th Street, Box 112, New York, NY 10032, USA. ag2965@columbia.edu.
Induced pluripotent stem cells (iPSCs) offer a revolutionary approach to studying and treating retinal diseases. This technology enables personalized medicine for conditions like macular degeneration, despite existing scientific and ethical challenges.
07:43Subretinal Transplantation of Human Embryonic Stem Cell-Derived Retinal Tissue in a Feline Large Animal Model
Published on: August 5, 2021
11:29Defined Xeno-free and Feeder-free Culture Conditions for the Generation of Human iPSC-derived Retinal Cell Models
Published on: September 6, 2018
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: